Analysts forecast that Alcentra Capital Corp (NASDAQ:ABDC) will report $6.61 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Alcentra Capital’s earnings. The highest sales estimate is $6.77 million and the lowest is $6.41 million. Alcentra Capital posted sales of $7.61 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 13.1%. The firm is scheduled to issue its next earnings report on Monday, November 5th.
According to Zacks, analysts expect that Alcentra Capital will report full-year sales of $28.68 million for the current fiscal year, with estimates ranging from $28.34 million to $29.01 million. For the next financial year, analysts expect that the company will post sales of $26.94 million, with estimates ranging from $25.00 million to $28.62 million. Zacks’ sales averages are a mean average based on a survey of research firms that follow Alcentra Capital.
Alcentra Capital (NASDAQ:ABDC) last posted its quarterly earnings data on Monday, August 6th. The asset manager reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.05. Alcentra Capital had a positive return on equity of 10.10% and a negative net margin of 43.78%. The company had revenue of $7.25 million during the quarter, compared to analysts’ expectations of $6.82 million.
NASDAQ:ABDC traded up $0.07 during trading hours on Thursday, reaching $5.82. 67,019 shares of the stock were exchanged, compared to its average volume of 65,103. Alcentra Capital has a twelve month low of $5.58 and a twelve month high of $9.01. The stock has a market capitalization of $78.74 million, a price-to-earnings ratio of 5.11 and a beta of 0.59.
Several institutional investors have recently bought and sold shares of ABDC. Salzhauer Michael increased its position in shares of Alcentra Capital by 100.8% during the second quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock worth $910,000 after acquiring an additional 124,057 shares during the period. Bank of New York Mellon Corp increased its position in shares of Alcentra Capital by 17.6% during the second quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock worth $4,019,000 after acquiring an additional 94,111 shares during the period. Finally, Belpointe Asset Management LLC purchased a new position in Alcentra Capital in the second quarter valued at $107,000. 33.59% of the stock is currently owned by institutional investors and hedge funds.
About Alcentra Capital
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
See Also: Institutional Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.